NEWNow you can listen to Fox News articles!
A California teen who once identified as transgender, took hormones and had surgery to confirm her identity, spoke out in favor of Blocking Florida Rules Medicaid funds medical interventions for gender dysphoria.
“I didn’t really understand the full implications of any of the medical decisions I was making,” Chloe Cole, 17, said at a public hearing on Friday. She said she went from 13 to 16 for medical reasons, taking so-called puberty-blocking drugs and testosterone, and had surgery to remove her breasts at 15. painful.”
“I don’t know if I will be able to fully bear a child, and I may have an increased risk of certain types of cancer, mostly cervical cancer“Cole said in a separate private meeting with Florida Surgeon General Joseph Ladapo on Friday, footage of which Ladapo posted to Twitter on Sunday. “And because I don’t have breasts, I can’t breastfeed my unborn babies.”
“That realization was actually one of the most important things that led me to realize that this was not the path I should have been on,” Cole added.
“No child should experience what I have,” she concluded.
When asked what she would say to the public, Cole replied, “Don’t transfer your kids.”
“If you’re thinking about transitioning, please wait until you’re a fully developed adult,” said Cole, whose Twitter handle is @ChoooCole, Fox News Digital. “The transition can damage your body and mind in ways we cannot fully understand.”
Ladapo also warned against transgender medical interventions for children.
“The medicalization of minors with gender dysphoria may help reinforce the political views of physicians treating them, but there is extremely little evidence to show any benefit for actual children,” Fox News Digital’s chief surgeon said. “The assertion model carries an unacceptably high risk of harm.”
“Parents are threatened with the fear of suicide, but treatment has not been proven to actually reduce this risk,” he added. “These patients need compassionate care for their emotional and mental well-being so they don’t get dragged into political views on sex/gender.”
Cole advocated Rule 59G-1050, which would have the Health Administration Agency (AHCA) limit Medicaid funding from transgender drugs and procedures. Under this rule, Florida Medicaid will not cover puberty blockers, hormones and hormone antagonists, sex reassignment surgery, or “any other procedure that changes primary or secondary sex characteristics” for the treatment of gender dysphoria.
AHCA communications director Brock Juarez praised Cole’s testimony as “very suggestive”. He also noted Recent AHCA Report finding that some gender dysphoria services “do not meet widely accepted professional medical standards and are experimental and exploratory and may have harmful long-term effects.”
Transgender activist groups, medical associations, and the American Academy of Pediatrics (AAP) have supported medical interventions for minors diagnosed with gender dysphoria, denouncing policies like those supported by Cole.
“The American Academy of Pediatrics recommends that youth who identify as transgender have access to comprehensive, gender-supportive and developmentally appropriate health care provided in a safe and inclusive clinical space,” the AAP wrote in March 2021 in a statement condemning laws against transgender health interventions for children.
Neither AAP nor the National Center for Transgender Equality responded to Fox News Media’s requests for comment.
In May 2021, the Biden administration and the Department of Health and Human Services (HHS) announced that the Office of Civil Rights would interpret and enforce Section 1557 of the Affordable Care Act and Title IX’s prohibition of sex discrimination, including sex discrimination. basis of gender identity. Last month, Biden signed the decree urging HHS to ensure that minors have access to transgender interventions.
Nonetheless medical community divided on this issue.
Dr. Matthew Benson, a board-certified pediatric endocrinologist based in Jacksonville, said he agreed with the AHCA rule. “I think the data on which the gender-affirming model is based is not scientific,” he said. He cited studies from Sweden and Denmark showing extremely high suicide rates among people taking transgender interventions and concluded: “We need better data, we need long-term prospective trials where we can look at side effects. We need much more reliable data. to justify these kinds of very reliable therapies.”
Most hormonal drugs are “approved by the Food and Drug Administration (FDA) only as puberty blockers in children for the treatment of central precocious puberty, not gender dysphoria,” says Dr. Michael Laidlaw, an independent endocrinologist in private practice in Rocklin, Calif., told Fox News in December. 2021. He blamed “off-label use of these medications to treat gender dysphoria”, stating that “blocking normal puberty has numerous unhealthy side effects, including loss of normal bone development, disruption of normal brain development and social development, and importantly, causes infertility and sexual dysfunction. dysfunction. Many of these effects will be irreversible.”